Published in Clin Case Rep on October 05, 2016
Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol (2000) 2.03
Articular manifestations in pulmonary diseases: an analysis of their occurrence in 1,024 cases in which pulmonary resection was performed. J Am Med Assoc (1954) 1.58
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest (1994) 1.57
Hypertrophic osteoarthropathy: consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol (1993) 1.30
Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum (2008) 1.21
Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer. J Thorac Oncol (2010) 1.15
Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure. Ind Health (2004) 1.09
Finger clubbing in malignant mesothelioma and benign asbestos pleural disease. Respir Med (1998) 1.00
Hypertrophic osteoarthropathy: what a rheumatologist should know about this uncommon condition. Rheum Dis Clin North Am (2013) 0.97
The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. Lung Cancer (2011) 0.96
Hypertrophic pulmonary osteoarthropathy associated with non-small cell lung cancer demonstrated growth hormone-releasing hormone by immunohistochemical analysis. Intern Med (2001) 0.90
Diagnosis and treatment of malignant pleural mesothelioma. Arch Bronconeumol (2014) 0.82
[A case of pulmonary hypertrophic osteoarthropathy associated with primary lung cancer in a young adult successfully treated with gefitinib]. Nihon Kokyuki Gakkai Zasshi (2007) 0.81
[A case of lung adenocarcinoma with Marie-Bamberger syndrome that improved by chemotherapy]. Nihon Kokyuki Gakkai Zasshi (2007) 0.79